Info

🌱 來自: Breast cancer main pathway

Node negative-of-Breast cancer main pathway

HR postive HER2 negative

T1 or T2 with N0M0

• Gene expression assay of Breast cancer
• Post-menopause adjuvant-of-Node negative-of-Breast cancer main pathway
  • Low risk→ adjuvant endocrine therapy for breast cancer
  • High risk → CAF x 6 followed by endocrine therapy
• Premenopause
  • Low risk→ adjuvant endocrine therapy for breast cancer
  • High risk → CAF x 6 → endocrine therapy

T3 or 4 N0M0

Chemotherapy-of-Node negative-of-Breast cancer

• T1a aka < 0.5cm: no C/T
• T1b 0.6~1 cm:
  1. Low risk: no C/T
  2. Others: Chemotherapy (optional)
• T1c C. >1cm
  1. Low risk : optional
  2. Others: CAF x 6 @
• D. Triple negative
  • AC × 4, Taxotere × 4 ( AC followed by T)